The present study has further demonstrated the use of combined CYFRA 21-1 and CRP as a prognostic marker in OSCC and may be significant as a biomarker to predict prognosis and stratify patients for adjuvant therapies in the absence of traditional indications such as lymph node ECS.
← all excerpts
Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
1
—
—